iData Research

Product Description

Overall, the global cerebral embolic protection device market was valued at $131 million in 2023. This is expected to increase over the forecast period at a CAGR of 12.8% to reach $305 million. Overall, the global pre-shaped guidewire market was valued at $108 million in 2023. This is expected to increase over the forecast period at a CAGR of 7.2% to reach $175 million.

The full report suite on the global market for cerebral embolic protection device (CEPD) includes filters designed to capture or deflect emboli traveling to the brain during transcatheter aortic valve implantation procedures in order to protect the supra-aortic vessels from embolic debris. The full report suite on the global market for pre-shaped guidewire includes curved guidewires that are used in transcatheter aortic valve implantation (TAVI) procedures to ensure correct placement of the TAVI device.

MARKET DATA INCLUDED

• Unit Sales, Average Selling Prices, Market Size & Growth Trends
• Procedure Volumes
• COVID-19 Impact Analysis
• Market Drivers & Limiters
• Market Forecasts Until 2030, and Historical Data to 2020
• Recent Mergers & Acquisitions
• Disease Overviews
• Company Profiles, Product Portfolios, and SWOT for Top Competitors

Cerebral Embolic Protection Device Market Insights

CEPDs are utilized in fewer than one-third of all transcatheter aortic valve replacement (TAVR) procedures. The adoption of the device is limited as only a few countries offer reimbursement, influencing many physicians to forgo its use. Additionally, approval for CEPDs remains pending in various regions of Asia-Pacific, Africa, and the Middle East. These constraints on reimbursement and approval are likely to continue hindering market growth. Despite these challenges, the CEPD market is poised for growth driven by an increasing number of TAVR procedures. In regions like Europe and North America, where CEPD use is more common, the market is expected to experience growth throughout the forecast period, fueled by the rising number of procedures.

Pre-Shaped Guidewire Market Insights

The global pre-shaped guidewire market is predominantly driven by four major players. As these companies engage in competitive pricing strategies, the potential for reduced market growth exists due to declining prices. However, this effect is somewhat counterbalanced by ongoing inflationary pressures across the global economy. As TAVR procedures increasingly become the standard of care worldwide, the demand for pre-shaped guidewires will correspondingly rise, supporting market growth throughout the forecast period.

MARKET SHARE INSIGHTS

Cerebral Embolic Protection Device Market:

In 2023, Boston Scientific dominated the global cerebral protection device market with its Sentinel™ cerebral protection product. The Sentinel™, a dual-filter embolic protection device, is widely used during TAVR procedures and continues to be the preferred choice worldwide. This popularity is projected to secure Boston Scientific a significant market share for the foreseeable future.

Venus MedTech holds the position of second-leading competitor in the global CEPD market. The acquisition of Keystone Heart and its TriGUARD 3™ CEPD has strengthened Venus MedTech’s presence in the market. With its growing regional influence and anticipated additional approvals, Venus MedTech is poised to increase its global market share in the coming years.

Pre-Shaped Guidewire Market:

In 2023, Boston Scientific emerged as the frontrunner in the pre-shaped guidewire market. The company boasts an extensive array of guidewires, with the Safari2™ pre-shaped guidewire leading in popularity. Despite facing competition from numerous local manufacturers, Boston Scientific is anticipated to retain its market share in the upcoming years.

Medtronic secured the position as the second-leading competitor in the same market during 2023. The company’s Confida™ Brecker guidewire, specifically designed for use in transcatheter aortic valve replacement (TAVR) procedures, competes directly with Boston Scientific as well as various local enterprises. However, Medtronic is likely to experience a slight decline in market share.

Cook Medical ranked third in the market, offering products such as the Lunderquist® and Amplatz Extra-Stiff pre-shaped guidewires. Although these products are not tailored for TAVR procedures, Cook Medical is expected to sustain its market position over the next few years, competing against Boston Scientific and other local companies.

RESEARCH SCOPE SUMMARY

FREE Sample Report